VYGR Stock Catapults Higher After Novartis Sweetens Its Gene Therapy Deal Novartis (NVS) expanded its gene therapy collaboration with Voyager Therapeutics (VYGR) on Monday. VYGR stock rocketed above its 200-day line for the first time in four months.